Here's a look at some of the top Wall Street stories for medical device companies this week: Ocular Therapeutix sets terms for IPO; Allergan renews fight against hostile Valeant takeover; Abbott to deal pharma line to Mylan for $5.3B; Exo-suit maker ReWalk files for $57.5M IPO; Intersect ENT sets terms for $65M IPO
Ocular Therapeutix sets terms for IPO
July 11, 2014 by Brad Perriello
Intersect ENT Inc., Mylan Inc., Ocular Therapeutix Inc., Pershing Square Capital Management, ReWalk Robotics, Valeant Pharmaceuticals, Abbott Laboratories, Allergan Inc.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1kzssRn
Cap comentari:
Publica un comentari a l'entrada